1. Home
  2. FVCB vs NYXH Comparison

FVCB vs NYXH Comparison

Compare FVCB & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FVCBankcorp Inc.

FVCB

FVCBankcorp Inc.

HOLD

Current Price

$16.05

Market Cap

229.7M

Sector

Finance

ML Signal

HOLD

Logo Nyxoah SA

NYXH

Nyxoah SA

HOLD

Current Price

$4.61

Market Cap

188.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVCB
NYXH
Founded
2007
2009
Country
United States
Belgium
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.7M
188.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FVCB
NYXH
Price
$16.05
$4.61
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$16.00
$11.67
AVG Volume (30 Days)
40.4K
44.5K
Earning Date
01-20-2026
03-12-2026
Dividend Yield
1.50%
N/A
EPS Growth
47.56
N/A
EPS
1.21
N/A
Revenue
$65,816,999.00
$6,616,215.00
Revenue This Year
$9.22
$75.27
Revenue Next Year
$7.13
$277.15
P/E Ratio
$13.21
N/A
Revenue Growth
13.25
10.96
52 Week Low
$9.49
$4.35
52 Week High
$16.34
$11.87

Technical Indicators

Market Signals
Indicator
FVCB
NYXH
Relative Strength Index (RSI) 78.21 44.96
Support Level $15.61 $4.70
Resistance Level $15.97 $4.70
Average True Range (ATR) 0.42 0.17
MACD 0.08 -0.03
Stochastic Oscillator 100.00 23.81

Price Performance

Historical Comparison
FVCB
NYXH

About FVCB FVCBankcorp Inc.

FVCBankcorp Inc is a registered bank holding company. It operates through the sole subsidiary, FVCbank which is a community-oriented, locally-owned, and managed commercial bank. It offers commercial banking services to small and medium-sized businesses, professionals, non-profit organizations and associations, and investors. It also provides retail banking services to accommodate the individual needs of both corporate customers as well as the communities it serves. The bank provides other facilities such as online banking, mobile banking, remote deposit service, and lending products, among others. Its primary source of revenue is the net interest income.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: